Vascular benefit of the use of mepivacaine as an anaesthetic in resilient hyaluronic acid® injectables

Lidocaine (0.3% w/w) has long been used in HA-based injectables for pain relief, but mepivacaine may be a better alternative, offering similar efficacy without vasodilation, potentially lowering the risk of adverse events.